DOWN-REGULATION OF CONNEXIN32 PROTEIN AND GAP-JUNCTIONAL INTERCELLULAR COMMUNICATION BY CYTOKINE-MEDIATED ACUTE-PHASE RESPONSE IN IMMORTALIZED MOUSE HEPATOCYTES
A. Temme et al., DOWN-REGULATION OF CONNEXIN32 PROTEIN AND GAP-JUNCTIONAL INTERCELLULAR COMMUNICATION BY CYTOKINE-MEDIATED ACUTE-PHASE RESPONSE IN IMMORTALIZED MOUSE HEPATOCYTES, Cell and tissue research, 294(2), 1998, pp. 345-350
In the present study, we have analyzed the direct effects of cytokines
, which mediate the acute-phase response in liver, on connexin express
ion and gap-junctional intercellular communication in immortalized MHS
V12 mouse hepatocytes. When these cells were stimulated for 24 h with
interleukin 1 and interleukin 6, the amount of connexin26 (Cx26) mRNA
increased together with beta-fibrinogen mRNA, as expected for this pos
itive acute-phase gene. In contrast, connexin32 (Cx32) mRNA expression
was not affected under these conditions. Indirect immunfluorescence r
evealed a drastic decrease in Cx32 signals, whereas slightly more Cx26
signals were found. Stronger stimulation with interleukin 1 and tumor
necrosis factor alpha gave a dose-dependent increase in steady state
levels of Cx26 and beta-fibrinogen mRNA, but no further change in Cx32
mRNA level was seen. However, when Cx32 protein was analyzed on immun
oblots, we found a 5-fold decrease in expression even at low cytokine
doses that did not affect Cx32 mRNA expression. Under these conditions
, cell to cell transfer of Lucifer yellow, microinjected into immortal
ized hepatocytes, was decreased by 70%, suggesting that intercellular
communication through Cx32 channels was partially inhibited earlier th
an other genetic alterations characteristic of the acute-phase respons
e. Thus, the major hepatic gap junction protein was largely downregula
ted at the beginning of the experimental inflammatory reaction, but ab
out 30% of gap-junctional intercellular communication was maintained.
This suggests that, during the acute-phase response, the second hepati
c Cx26 protein may compensate in part for the downregulation of the Cx
32 protein.